Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

NCT00170755 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
January 31, 2005
Enrollment
718 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder syndrome